[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Palmer, 1940 - Google Patents

A simple method for preparing antigenic substances from the typhoid bacillus

Palmer, 1940

Document ID
3167643631753219642
Author
Palmer J
Publication year
Publication venue
Science

External Links

Snippet

SUMMARY A common and highly destructive dietary disease of silver foxes in captivity is pathologically the counter-part of Wernicke's hemorrhagic polioencephalitis of man.. The disease in foxes is caused by feeding fish as 10 per cent., or more, of the diet. It is probable …
Continue reading at www.science.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/867—Diarrhea

Similar Documents

Publication Publication Date Title
Palmer A simple method for preparing antigenic substances from the typhoid bacillus
Bills Physiology of the sterols, including vitamin D
Sugimura et al. Carcinogenic action of N-methyl-N′-nitro-N-nitrosoguanidine
DE3227262C3 (en) Process for the preparation of human tumor necrosis factor and human tumor necrosis factor
DE69322896T2 (en) Use of proteins from the transferrin / lactoferrin family to stimulate the immune system
DE3433339C2 (en) Medicinal products containing cell membrane proteins for the treatment of autoimmune diseases and processes for their production
Bekesi et al. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon
DE3001585A1 (en) METHOD FOR PRODUCING INTERFERON TYPE II AND PREPARATIONS CONTAINING IT
DE3856059T2 (en) Peptide determinant affecting immunity
Truscott Endotoxin studies in chicks: effect of lead acetate
Housley et al. Immune response to gluten in adult coeliac disease
DE3786304T2 (en) Immunostimulating drugs.
DE3418820A1 (en) MEDICINES FOR DIGESTIVE Ulcers
Chatterjee On the presence of an antidiabetic principle in Momordica charantia
Foot Eosinophil turnover in the rat
Wharton et al. Further Studies of the Immunological Properties of Polysaccharides from Serratia Marcescens (Bacillus Prodigiosus) II. Nature of the Antigenic Action and the Antibody Response in Mice
JP3054194B2 (en) Immunosuppressive products
DE3782996T2 (en) CELL MEMBRANE PROTEINS, PREPARATIONS THAT CONTAIN IT AND METHOD FOR THEIR PRODUCTION.
CH653557A5 (en) THERAPEUTIC AGENT SUITABLE FOR TREATING ALLERGIC CONDITIONS, IMMUNE COMPLEX DISEASES AND TUMORS.
DE3720434A1 (en) METHOD FOR PRODUCING SPECIFIC IMMUNOMODULATORS FOR THE TREATMENT OF VIRUS-INDEX CAUSED BY VIRUSES AND MEDICINAL PRODUCT CONTAINING THE SAME
Macht et al. Physiological and toxicological effects of some fish muscle extracts
DE3236298C2 (en)
US11129857B2 (en) Antivenom compositions and uses thereof
DE3123830A1 (en) "ANTIVIRUS SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF"
Salvin et al. Resistance and susceptibility to infection in inbred murine strains. III. Effect of thymosin on cellular immune responses of alloxan diabetic mice.